Combined detection of circulating tumor cells, α-fetoprotein heterogene-3 and α-fetoprotein in the early diagnosis of HCC for the prediction of efficacy, prognosis, recurrence after microwave ablation

Table 5 Comparison of Serum AFP, AFP-L3, and CTCs Levels between Non-recurrent Group and Recurrent Group Relapsed before and after Microwave Ablation of Liver Cancer

Group	Time	Cases	AFP(ng/mL)	AFP-L3(%)	CTCs
Non-recurrence Group	Before surgery	57	157.34(67.93~508.71)	14.72(13.87~15.65)	2.23(1.95~2.53)
Non-recurrence Group	6 months after surgery	57	62.17(38.57~107.76)^a	7.01(5.13~8.93)^a	1.70(1.52~1.91)^a
Recurrence Group	Before surgery	48	216.82(97.12~731.85)^a	17.51(15.44~19.26)^a	2.65(2.14~2.93)^a
Recurrence Group	6 months after surgery	48	351.06(216.84~485.29)^ab	21.38(18.91~23.73)^ab	3.05(2.62~3.31)^ab

Note: Compared with the non-recurring group before surgery, ^aP<0.05; compared with the non-recurring group at 6 months after surgery, ^bP<0.05

ISSN: 1750-9378